Centre Georges Francois Leclerc
Clinical trials sponsored by Centre Georges Francois Leclerc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Taste test: could your food cravings predict malnutrition during cancer treatment? Results expected Oct 2026 (estimated)
- Could zapping the spleen fix Chemo's side effect? Results expected Dec 2026 (estimated)
- New personalized vaccine takes on tough cancers Results expected May 2027 (estimated)
-
New combo therapy aims to boost lung cancer treatment
Disease control Recruiting nowThis study tests whether adding a short course of a MEK inhibitor (mirdametinib) to standard chemoimmunotherapy is safe and effective for people with advanced non-squamous non-small cell lung cancer that has low PDL1 levels. The trial has two parts: first finding the best dose, t…
Phase 1/2 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Deep gene search aims to uncover why some young people get cancer
Knowledge-focused Recruiting nowThis study looks at people who developed cancer at a young age (before 40, or before 30 for breast cancer) but had normal results on standard genetic tests. Researchers will use a more advanced technique called exome sequencing to search for new genetic changes that might raise c…
Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Deeper DNA analysis may unlock better cancer care
Knowledge-focused Recruiting nowThis study is testing whether a more detailed genetic analysis of tumors (called 'complex' exome analysis) helps doctors choose better treatments for people with advanced solid tumors compared to a standard genetic analysis. About 8,000 participants will have their tumor and norm…
Phase 2 • Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC